NeurosciencebioRxivPreprint
Neuroprotective activity of sub-anesthetic ketamine in a preclinical model of Parkinson's disease is not blocked by antagonizing brain-derived neurotrophic factor signaling
Carolyn J. Stopera, Mitchell J. Bartlett, Kelsey Bernard…·Torsten Falk
This study shows that low-dose ketamine protects against Parkinson's-like motor deficits in rats without relying on BDNF-TrkB signaling.
DOI 10.64898/2026.10.28.762430